Mandate

Vinge advises Active Biotech on rights offering

February 15, 2018 Capital Markets and Public M&A

Active Biotech AB (publ) issues new shares with pre-emptive rights for the shareholders.

The Vinge team includes Erik Sjöman, Christian Lindhé, Astrid Karlsson and Jack Bengtsson.
 

Related

Vinge represents Cinven in connection with the acquisition of Ongoing Warehouse

Vinge has represented the international private equity firm Cinven in connection with its acquisition of Ongoing Warehouse.
May 06, 2026

Vinge advises Fazer in connection with its acquisition of Aroma

Fazer has entered into an agreement to acquire Konfektyrfabriken Aroma AB, a Swedish confectionery manufacturer known for its classic candy products such as Geléhallon, Hallonbåtar, Röda Hjärtan and Gräddkola. The acquisition strengthens Fazer's position in the Swedish confectionery market, particularly within pick & mix, packed candy, and seasonal products. The acquisition is subject to customary regulatory approvals.
May 06, 2026

Vinge represents Investor in connection with Electrolux Group’s rights issue

Vinge represents Investor AB (publ) (“Investor”) in connection with Electrolux Group’s rights issue of approximately SEK 9 billion. Investor has undertaken to subscribe for Investor’s pro rata share, corresponding to approximately SEK 1.7 billion, and in addition to guarantee approximately SEK 1.7 billion.
May 06, 2026